Lundbeck Logo
Newsroom
  • Home
  • Science
  • Patient Voices
  • Our Impact
  • News Releases
Thomas Gibbs to join Lundbeck as Executive Vice President and Head of Lundbeck in the United States
News Releases
Thomas Gibbs to join Lundbeck as Executive Vice President and Head of Lundbeck in the United States
Read Story
0
share
Otsuka and Lundbeck announce FDA acceptance and priority review of sNDA for brexpiprazole for the treatment of agitation associated with Alzheimer’s dementia
News Releases
Otsuka and Lundbeck announce FDA acceptance and priority review of sNDA for brexpiprazole for the treatment of agitation associated with Alzheimer’s dementia
Read Story
0
share
Otsuka Pharmaceutical And Lundbeck Present Positive Data From Multiple Phase 3 Studies Showing Brexpiprazole Significantly Improved Symptoms Of Agitation In Patients With Alzheimer’s Dementia At The 2022 Clinical Trials For Alzheimer’s Disease Congress
News Releases
Otsuka Pharmaceutical And Lundbeck Present Positive Data From Multiple Phase 3 Studies Showing Brexpiprazole Significantly Improved Symptoms Of Agitation In Patients With Alzheimer’s Dementia At The 2022 Clinical Trials For Alzheimer’s Disease Congress
Read Story
0
share
Otsuka and Lundbeck Announce U.S. FDA Acceptance of New Drug Application for Aripiprazole 2-month, Ready-to-Use, Long-acting Injectable to Treat Schizophrenia and Bipolar I Disorder in Adults
News Releases
Otsuka and Lundbeck Announce U.S. FDA Acceptance of New Drug Application for Aripiprazole 2-month, Ready-to-Use, Long-acting Injectable to Treat Schizophrenia and Bipolar I Disorder in Adults
Read Story
0
share
Otsuka Pharmaceutical and Lundbeck present positive results showing reduced agitation in patients with Alzheimer’s dementia treated with brexpiprazole at the 2022 Alzheimer's Association International Conference
News Releases
Otsuka Pharmaceutical and Lundbeck present positive results showing reduced agitation in patients with Alzheimer’s dementia treated with brexpiprazole at the 2022 Alzheimer's Association International Conference
Read Story
0
share
  • Contact US
  • Terms of Use
  • Privacy Policy
  • Report an Adverse Drug Reaction

This site contains medical information that is intended for residents of the United States only and is not meant to substitute for the advice provided by a medical professional. Always consult a physician if you have health concerns. Use and access of this site are subject to the terms and conditions as set out in our Privacy Policy and Terms of Use. 

© Copyright 2023 Lundbeck. All rights reserved.

Leaving Site

You are about to leave the NewsRoom website and enter a website operated by an independent third party. The links to third-party websites are provided solely for your convenience. Lundbeck does not control the opinions, claims, or comments contained on any third-party website linked to Newsroom.LundbeckUS.com, and your activities at those websites will be governed by the policies and practices of those third parties.

Select "OK" to proceed to this third-party website or "Cancel" to stay at Newsroom.LundbeckUS.com.